American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Precision lineage deconvolution in mixed phenotype acute leukemia using CITE-seq derived hematopoietic stages identifies lineage dynamics associated with treatment response
    Meeting Abstract

    Dilip, D.; Galera, P.; Nemirovsky, D.; Lallo, M.; Menghrajani, K.; Derkach, A.; Levine, R. L.; Koche, R.; Xiao, W.; Glass, J.
    Blood (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma -Real world experience
    Meeting Abstract

    Luttwak, E.; Ganesan, N.; Boardman, A. P.; Caron, P.; David, K. A.; Rivas-Delgado, A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Radiation and busulfan-free hematopoietic stem cell transplantation using briquilimab (JSP191) anti-CD117 antibody-conditioning, transient immunosuppression and TCRαβ (+) T-cell/CD19 (+) B-cell depleted haploidentical grafts in patients with fanconi anemia
    Meeting Abstract

    Agarwal, R.; Bertaina, A.; Soco, C. F.; Saini, G.; Kunte, N.; Hiroshima, L.; Chan, Y. Y.; Willner, H.; Krampf, M. L.; Nofal, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Data-driven harmonization of 2022 WHO and ICC classifications of myelodysplastic syndromes/neoplasms (MDS): A study by the International Consortium for MDS (icMDS)
    Meeting Abstract

    Lanino, L.; Ball, S.; Bewersdorf, J. P.; Marchetti, M.; Maggioni, G.; Travaglino, E.; Al Ali, N. H.; Fenaux, P.; Platzbecker, U.; Santini, V.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Risk factors and outcomes for hematotoxicity following tisagenlecleucel for pediatric B-acute lymphoblastic leukemia
    Meeting Abstract

    McNerney, K. O.; Fabrizio, V. A.; Talleur, A. C.; Lim, S. S.; Dreyzin, A.; Baggott, C.; Vatsayan, A.; Rossoff, J.; Prabhu, S.; Pacenta, H. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Biological and clinical significance of undetectable circulating tumor cells (CTCs) in patients (pts) with multiple myeloma (MM)
    Meeting Abstract

    Garcés, J. J.; Termini, R.; Martín-Sánchez, E.; Lasa, M.; Perez, J. J.; Gutierrez, N. C.; Fernández, M.; Calasanz, M. J.; Rosiñol, L.; Garcia, M. T. H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Post-Hoc analysis of measurable residual disease from BMT-CTN 1506/MORPHO: FLT3-ITD variant allele frequency and survival are highly correlated
    Meeting Abstract

    Levis, M. J.; Hamadani, M.; Logan, B. R.; Jones, R. J.; Singh, A. K.; Litzow, M. R.; Wingard, J. R.; Papadopoulos, E. B.; Perl, A.; Soiffer, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • DNA methylation-based classification of hairy cell leukemia and splenic B cell lymphoma
    Meeting Abstract

    Yamaguchi, K.; Abdelbaky, S.; Arons, E.; Cross, M.; Wu, Y. Z.; Weigel, C.; Anghelina, M. I.; Parker, H.; Kibler, A.; Salido, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Pirtobrutinib in relapsed/refractory (R/R) mantle cell lymphoma (MCL) patients with prior cBTKi: Safety and efficacy including high-risk subgroup analyses from the phase 1/2 BRUIN study
    Meeting Abstract

    Cohen, J. B.; Shah, N. N.; Jurczak, W.; Zinzani, P. L.; Cheah, C. Y.; Eyre, T. A.; Ujjani, C. S.; Koh, Y.; Kim, W. S.; Nasta, S. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Pirtobrutinib in post-cBTKi CLL/SLL: ∼30 months follow-up and subgroup analysis with/without prior BCL2i from the phase 1/2 BRUIN study
    Meeting Abstract

    Woyach, J. A.; Brown, J. R.; Ghia, P.; Roeker, L. E.; Patel, K.; Eyre, T. A.; Munir, T.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; more...
    Blood (2023)

    Fulltext@MSK | Save